冷痛療法市場：製品、流通チャネル、用途別-2025-2030年の世界予測

冷痛療法市場は、2023年に20億5,000万米ドルと評価され、2024年には22億2,000万米ドルに達すると予測され、CAGR 8.20％で成長し、2030年には35億6,000万米ドルに達すると予測されています。

冷痛療法とは、痛みや炎症を緩和するための冷熱治療のことです。アイスパック、ジェル、スプレー、凍結療法を行う装置など、さまざまな製品が含まれます。冷痛療法の必要性は、その非侵襲的な性質と、スポーツ傷害、慢性疼痛、筋骨格系障害の有病率の増加によって強調されています。スポーツ医学、整形外科、在宅医療など様々な分野で応用されています。最終用途には、個人消費者、プロスポーツ選手、理学療法クリニック、ヘルスケア施設などが含まれます。市場成長の原動力は、高齢化、ヘルスケア意識の高まり、非薬物療法の需要です。ウェアラブルなコールドセラピー機器や、生分解性で環境に優しいパッケージングの技術革新などの技術的進歩からビジネスチャンスが生まれます。特に、パンデミック後の消費者の購買習慣の変化に伴い、オンライン小売の増加も市場拡大の新たなチャネルとなります。しかし課題としては、皮膚刺激や凍傷のような副作用の可能性や、代替療法の利用可能性などが挙げられます。競合情勢は、主要企業が製品の差別化と戦略的提携に注力する中で激化しています。製品ライフサイクルや季節的な需要変動に起因する限界や、温熱療法などの代替療法との競合が成長を阻害する可能性もあります。革新的な治療分野としては、個別化治療のためのIoT対応凍結療法ソリューションや、標的を絞った低温療法アプリケーションの開発などがあり、皮膚治療や術後の回復に新たな道を開く可能性があります。企業は、安全性への懸念に対処するための研究開発に投資し、消費者への製品教育を重視することで成長できます。さらに、ヘルスケアへの投資が増加している新興市場を開拓し、流通網を拡大することで、未開拓の機会を捉えることができます。この市場の性質はダイナミックであり、伝統的な治療と現代的な治療の嗜好が融合してその進化を形成しているため、消費者のニーズや技術の進歩に絶えず適応することが求められます。

市場力学：急速に進化する冷痛療法市場の主要市場インサイトを公開

冷痛療法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • スポーツ活動、運動、ジムでの怪我の発生率の増加
  • 老年人口の増加と冷痛療法の採用
  • 世界の医療費の伸びとインフラ整備
• 市場抑制要因
  • 冷痛療法に関する認知度の低さ
  • 治療に伴う副作用や不快感
• 市場機会
  • 冷痛療法の有効性の向上
  • 冷痛療法の最近の動向と革新的な発売
• 市場の課題
  • 償還不足と代替療法の利用可能性

ポーターの5つの力：冷痛療法市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：冷痛療法市場における外部からの影響の把握

外部マクロ環境要因は、冷痛療法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析冷痛療法市場における競合情勢の把握

冷痛療法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス冷痛療法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、冷痛療法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨冷痛療法市場における成功への道筋を描く

冷痛療法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • スポーツ活動、運動、ジムでの運動中の傷害発生率の増加
    • 高齢者人口の増加と冷感鎮痛療法の導入
    • 世界中で医療費支出とインフラ整備が増加
  • 抑制要因
    • 寒冷疼痛治療に関する認識の低さ
    • 治療に伴う副作用や不快感
  • 機会
    • 冷痛療法の有効性の向上
    • 冷痛療法における最近の動向と革新的な発売
  • 課題
    • 償還と代替療法の利用可能性の欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 冷痛療法市場：製品別

• 市販薬
  • 保冷パック
  • ジェル、軟膏、クリーム
  • パッチ
  • ロールオン
  • スプレー＆フォーム
• 処方薬
  • 電動デバイス
  • 非電動デバイス

第7章 冷痛療法市場：流通チャネル別

• eコマース
• 病院薬局
• 小売薬局

第8章 冷痛療法市場：用途別

• 整形外科疾患
• 術後療法
• 心的外傷後療法
• スポーツ医学

第9章 南北アメリカの冷痛療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の冷痛療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの冷痛療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Beiersdorf AG
• Breg, Inc. by Orthofix US LLC
• Brownmed, Inc.
• Cardinal Health, Inc.
• Compass Health Brands
• DJO, LLC
• Hisamitsu Pharmaceutical Co., Inc.
• Iovera by Pacira BioSciences, Inc.
• Johnson & Johnson Services, Inc.
• Medline Industries, LP
• Performance Health Holding, Inc. by Patterson Medical
• Sanofi S.A.
• Unexo Life Sciences Pvt. Ltd.
• Ossur hf

LIST OF FIGURES

• FIGURE 1. COLD PAIN THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. COLD PAIN THERAPY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COLD PAIN THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COLD PAIN THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COLD PAIN THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COLD PAIN THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COLD PAIN THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COLD PAIN THERAPY MARKET DYNAMICS
• TABLE 7. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY COLD PACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY GELS, OINTMENTS & CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY ROLL-ONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY SPRAYS & FOAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY MOTORIZED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY NON-MOTORIZED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY ORTHOPEDIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY POST-OPERATIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY POST-TRAUMA THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL COLD PAIN THERAPY MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. CANADA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. CANADA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES COLD PAIN THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. CHINA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. CHINA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 78. INDIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. INDIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA COLD PAIN THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. ITALY COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. ITALY COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 184. POLAND COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. POLAND COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 189. QATAR COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. QATAR COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM COLD PAIN THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM COLD PAIN THERAPY MARKET SIZE, BY OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM COLD PAIN THERAPY MARKET SIZE, BY PRESCRIPTION PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM COLD PAIN THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM COLD PAIN THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. COLD PAIN THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. COLD PAIN THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

The Cold Pain Therapy Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.22 billion in 2024, and is projected to grow at a CAGR of 8.20%, to USD 3.56 billion by 2030.

Cold pain therapy refers to the use of cold treatment to alleviate pain and inflammation. It encompasses a range of products including ice packs, gels, sprays, and devices to deliver cryotherapy. The necessity of cold pain therapy is underscored by its non-invasive nature and the increasing prevalence of sports injuries, chronic pain, and musculoskeletal disorders. It finds applications across various sectors such as sports medicine, orthopedics, and home care. The end-use scope involves individual consumers, professional athletes, physiotherapy clinics, and healthcare facilities. Market growth is driven by an aging population, rising healthcare awareness, and the demand for non-pharmacological treatments. Opportunities arise from technological advancements such as wearable cold therapy devices and innovations in biodegradable and eco-friendly packaging. Increased online retailing offers another channel for market expansion, particularly as consumer shopping habits evolve post-pandemic. However, challenges include potential side effects like skin irritation or frostbite and the availability of alternative therapies. The competitive landscape is intensifying with key players focusing on product differentiation and strategic partnerships. Limitations stem from the product lifecycle and seasonal demand fluctuations, while competition from alternative modalities such as thermal therapy could hinder growth. Innovation areas include IoT-enabled cryotherapy solutions for personalized treatment and the development of targeted cold therapy applications, potentially opening new avenues in therapeutic skin care and post-operative recovery. Businesses can thrive by investing in R&D to address safety concerns and emphasizing product education to consumers. Furthermore, tapping into emerging markets with increasing healthcare investments and expanding the distribution network will help capture untapped opportunities. The nature of this market is dynamic, with a blend of traditional and modern treatment preferences shaping its evolution, demanding continual adaptation to consumer needs and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold Pain Therapy Market

The Cold Pain Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the incidence of injuries during sports activity, exercise, and gyming
  • Rising geriatric population and adoption of cold pain therapies
  • Growth in health care expenditure and infrastructure development worldwide
• Market Restraints
  • Limited awareness regarding cold pain therapies
  • Side effects, and discomfort associated with the treatment
• Market Opportunities
  • Improvements in efficacy of cold pain therapy
  • Recent developments and innovative launches in the cold pain therapy
• Market Challenges
  • Lack of reimbursement and availability of substitute therapies

Porter's Five Forces: A Strategic Tool for Navigating the Cold Pain Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold Pain Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold Pain Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold Pain Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold Pain Therapy Market

A detailed market share analysis in the Cold Pain Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold Pain Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold Pain Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold Pain Therapy Market

A strategic analysis of the Cold Pain Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold Pain Therapy Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Beiersdorf AG, Breg, Inc. by Orthofix US LLC, Brownmed, Inc., Cardinal Health, Inc., Compass Health Brands, DJO, LLC, Hisamitsu Pharmaceutical Co., Inc., Iovera by Pacira BioSciences, Inc., Johnson & Johnson Services, Inc., Medline Industries, LP, Performance Health Holding, Inc. by Patterson Medical, Sanofi S.A., Unexo Life Sciences Pvt. Ltd., and Ossur hf.

Market Segmentation & Coverage

This research report categorizes the Cold Pain Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across OTC Products and Prescription Products. The OTC Products is further studied across Cold Packs, Gels, Ointments & Creams, Patches, Roll-Ons, and Sprays & Foams. The Prescription Products is further studied across Motorized Devices and Non-Motorized Devices.
• Based on Distribution Channel, market is studied across E-commerce, Hospital Pharmacy, and Retail Pharmacy.
• Based on Application, market is studied across Orthopedic Conditions, Post-Operative Therapy, Post-Trauma Therapy, and Sports Medicine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the incidence of injuries during sports activity, exercise, and gyming
    • 5.1.1.2. Rising geriatric population and adoption of cold pain therapies
    • 5.1.1.3. Growth in health care expenditure and infrastructure development worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness regarding cold pain therapies
    • 5.1.2.2. Side effects, and discomfort associated with the treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements in efficacy of cold pain therapy
    • 5.1.3.2. Recent developments and innovative launches in the cold pain therapy
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of reimbursement and availability of substitute therapies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cold Pain Therapy Market, by Product

• 6.1. Introduction
• 6.2. OTC Products
  • 6.2.1. Cold Packs
  • 6.2.2. Gels, Ointments & Creams
  • 6.2.3. Patches
  • 6.2.4. Roll-Ons
  • 6.2.5. Sprays & Foams
• 6.3. Prescription Products
  • 6.3.1. Motorized Devices
  • 6.3.2. Non-Motorized Devices

7. Cold Pain Therapy Market, by Distribution Channel

• 7.1. Introduction
• 7.2. E-commerce
• 7.3. Hospital Pharmacy
• 7.4. Retail Pharmacy

8. Cold Pain Therapy Market, by Application

• 8.1. Introduction
• 8.2. Orthopedic Conditions
• 8.3. Post-Operative Therapy
• 8.4. Post-Trauma Therapy
• 8.5. Sports Medicine

9. Americas Cold Pain Therapy Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cold Pain Therapy Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cold Pain Therapy Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Beiersdorf AG
• 3. Breg, Inc. by Orthofix US LLC
• 4. Brownmed, Inc.
• 5. Cardinal Health, Inc.
• 6. Compass Health Brands
• 7. DJO, LLC
• 8. Hisamitsu Pharmaceutical Co., Inc.
• 9. Iovera by Pacira BioSciences, Inc.
• 10. Johnson & Johnson Services, Inc.
• 11. Medline Industries, LP
• 12. Performance Health Holding, Inc. by Patterson Medical
• 13. Sanofi S.A.
• 14. Unexo Life Sciences Pvt. Ltd.
• 15. Ossur hf